Entrada Therapeutics Statistics
NASDAQ: TRDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.35-0.29 (-6.25%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Entrada Therapeutics by the numbers
Entrada Therapeutics has a market capitalization of $170.3 million based on 39.15M shares outstanding. With trailing EPS of $-3.84, Entrada Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.1% below its 50-day average and 47.6% below its 200-day average.
Average daily trading volume is 401.15K shares, or about $1.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TRDA valuation vs. peer median
| Metric | TRDA | Peer median | Difference |
|---|---|---|---|
| Market cap | $170.30M | $174.39M | -2% |
| Avg. volume | 401.15K | 177.13K | +126% |
Peer median across 8 companies: SIGA, KRRO, ABEO, VOGX, NATR, EMIS, ADCT, SLGL.
Valuation
- Market cap
- $170.30M
- Price / sales (latest FY)
- 6.70
- EPS (TTM)
- $-3.84
- Shares outstanding
- 39.15M
Price and trading
- Previous close
- 4.64
- Open
- 4.55
- Day range
- 4.32 – 4.58
- 52-week range
- 4.11 – 16.45
- 52-week change
- -56.97%
- Beta
- —
- Volume
- 347.92K
- Average volume
- 401.15K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 170.30M
- Forward Pe
- -1.27
- Eps
- -3.84
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.45
- Week52 Low
- 4.11
- Avg Volume
- 401.15K
- Shares Outstanding
- 39.15M
- Ma50
- 5.38
- Ma200
- 8.30
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -73.56%
- Pct From52w Low
- 5.87%